Ignite Creation Date:
2025-12-24 @ 3:02 PM
Ignite Modification Date:
2026-02-03 @ 1:37 AM
Study NCT ID:
NCT00002659
Status:
UNKNOWN
Last Update Posted:
2013-12-19
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer
Sponsor:
Matrix Pharmaceutical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1995-05
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
1999-11-01
First Submit QC Date:
None
Study First Post Date:
2004-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-12-18
Last Update Post Date:
2013-12-19
Last Update Post Date Type:
ESTIMATED